Ultime notizie per Paychex (NASDAQ:PAYX) Azioni

PAYCHEX INC

Paychex

Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, founded in 1971, services over 745,000 clients and pays 1 in 12 US private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.

Remarks From Ryan Cohen

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

$BTC

CTAS

DLTR

PAYX

Con i futures azionari statunitensi scambiati in modo misto nella mattinata di mercoledì, alcuni dei titoli che potrebbero attirare l’attenzione degli investitori oggi sono i seguenti:

Dollar Tree, GameStop e Paychex tra i titoli da tenere d&#39;occhio oggi

Long Ideas

Analisi delle principali azioni industriali da considerare per gli investimenti di dicembre 2024. Ecco quali sono.

Le 3 migliori azioni industriali da acquistare a dicembre 2024

Paychex Inc

Barclays analyst Ramsey El-Assal maintains Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) with a Equal-Weight and raises the price target from $140 to $155.

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on Paychex, Raises Price Target to $155

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Industrials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>JELD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$5.00</td>
<td>$75.0K</td>
<td>1.4K</td>
<td align="right">998</td>
</tr>
<tr>
<td>UAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/11/25</td>
<td>$71.00</td>
<td>$30.0K</td>
<td>2</td>
<td align="right">247</td>
</tr>
<tr>
<td>UBER</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$75.00</td>
<td>$38.9K</td>
<td>1.5K</td>
<td align="right">153</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$180.00</td>
<td>$84.9K</td>
<td>262</td>
<td align="right">151</td>
</tr>
<tr>
<td>PAYX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$150.00</td>
<td>$26.8K</td>
<td>38</td>
<td align="right">133</td>
</tr>
<tr>
<td>DE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/04/25</td>
<td>$480.00</td>
<td>$29.5K</td>
<td>35</td>
<td align="right">117</td>
</tr>
<tr>
<td>SMR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$15.00</td>
<td>$50.8K</td>
<td>136</td>
<td align="right">117</td>
</tr>
<tr>
<td>HON</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$220.00</td>
<td>$49.9K</td>
<td>6.3K</td>
<td align="right">94</td>
</tr>
<tr>
<td>GE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/02/25</td>
<td>$210.00</td>
<td>$26.0K</td>
<td>69</td>
<td align="right">51</td>
</tr>
<tr>
<td>URI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/11/25</td>
<td>$602.50</td>
<td>$98.3K</td>
<td>1</td>
<td align="right">50</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For JELD (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JELD#NYSE">JELD</a>), we notice a call option sweep that happens to be bullish, expiring in 112 day(s) on July 18, 2025. This event was a transfer of 500 contract(s) at a $5.00 strike. This particular call needed to be split into 29 different trades to become filled. The total cost received by the writing party (or parties) was $75.0K, with a price of $150.0 per contract. There were 1418 open contracts at this strike prior to today, and today 998 contract(s) were bought and sold. 
• Regarding UAL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>), we observe a call option sweep with bearish sentiment. It expires in 14 day(s) on April 11, 2025. Parties traded 100 contract(s) at a $71.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $30.0K, with a price of $300.0 per contract. There were 2 open contracts at this strike prior to today, and today 247 contract(s) were bought and sold. 
• For UBER (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), we notice a put option trade that happens to be neutral, expiring in 175 day(s) on September 19, 2025. This event was a transfer of 45 contract(s) at a $75.00 strike. The total cost received by the writing party (or parties) was $38.9K, with a price of $865.0 per contract. There were 1590 open contracts at this strike prior to today, and today 153 contract(s) were bought and sold. 
• Regarding BA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), we observe a call option trade with bearish sentiment. It expires in 357 day(s) on March 20, 2026. Parties traded 36 contract(s) at a $180.00 strike. The total cost received by the writing party (or parties) was $84.9K, with a price of $2360.0 per contract. There were 262 open contracts at this strike prior to today, and today 151 contract(s) were bought and sold. 
• For PAYX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>), we notice a put option trade that happens to be bearish, expiring in 49 day(s) on May 16, 2025. This event was a transfer of 64 contract(s) at a $150.00 strike. The total cost received by the writing party (or parties) was $26.8K, with a price of $420.0 per contract. There were 38 open contracts at this strike prior to today, and today 133 contract(s) were bought and sold. 
• Regarding DE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), we observe a put option sweep with bearish sentiment. It expires in 7 day(s) on April 4, 2025. Parties traded 16 contract(s) at a $480.00 strike. This particular put needed to be split into 16 different trades to become filled. The total cost received by the writing party (or parties) was $29.5K, with a price of $1845.0 per contract. There were 35 open contracts at this strike prior to today, and today 117 contract(s) were bought and sold. 
• For SMR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>), we notice a call option trade that happens to be bullish, expiring in 238 day(s) on November 21, 2025. This event was a transfer of 117 contract(s) at a $15.00 strike. The total cost received by the writing party (or parties) was $50.8K, with a price of $435.0 per contract. There were 136 open contracts at this strike prior to today, and today 117 contract(s) were bought and sold. 
• Regarding HON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>), we observe a call option trade with neutral sentiment. It expires in 175 day(s) on September 19, 2025. Parties traded 49 contract(s) at a $220.00 strike. The total cost received by the writing party (or parties) was $49.9K, with a price of $1020.0 per contract. There were 6306 open contracts at this strike prior to today, and today 94 contract(s) were bought and sold. 
• For GE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), we notice a call option sweep that happens to be bullish, expiring in 35 day(s) on May 2, 2025. This event was a transfer of 50 contract(s) at a $210.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $26.0K, with a price of $512.0 per contract. There were 69 open contracts at this strike prior to today, and today 51 contract(s) were bought and sold. 
• For URI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>), we notice a put option sweep that happens to be bearish, expiring in 14 day(s) on April 11, 2025. This event was a transfer of 80 contract(s) at a $602.50 strike. This particular put needed to be split into 30 different trades to become filled. The total cost received by the writing party (or parties) was $98.3K, with a price of $1230.0 per contract. There were 1 open contracts at this strike prior to today, and today 50 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

JELD

UBER

10 Industrials Stocks With Whale Alerts In Today's Session

Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Paychex and provided 12-month price targets. The average target is $152.75, accompanied by a high estimate of $158.00 and a low estimate of $142.00. This current average has increased by 6.26% from the previous average price target of $143.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1743098466_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Paychex. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$142.00</td>
<td>$137.00</td>
</tr>
<tr>
<td>Peter Christiansen</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$158.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Bryan Bergin</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$156.00</td>
<td>$141.00</td>
</tr>
<tr>
<td>Kevin Mcveigh</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$155.00</td>
<td>$152.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Paychex. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Paychex compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Paychex's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Paychex's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PAYX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Paychex analyst ratings.</a>
<h2>Delving into Paychex's Background</h2>
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, founded in 1971, services over 745,000 clients and pays 1 in 12 US private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
<h3>Paychex: Delving into Financials</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Paychex's remarkable performance in 3 months is evident. As of 30 November, 2024, the company achieved an impressive revenue growth rate of 4.69%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Paychex's net margin excels beyond industry benchmarks, reaching 31.39%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Paychex's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 10.63%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Paychex's ROA stands out, surpassing industry averages. With an impressive ROA of 3.93%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Paychex's debt-to-equity ratio is below the industry average. With a ratio of 0.22, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Paychex's Future

Morgan Stanley analyst James Faucette maintains Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) with a Equal-Weight and raises the price target from $137 to $142.

Morgan Stanley Maintains Equal-Weight on Paychex, Raises Price Target to $142

RBC Capital Markets analyst Ashish Sabadra on Wednesday reiterated a <a target="_blank" href="https://www.benzinga.com/quote/PAYX/analyst-ratings" rel="noreferrer noopener">Sector Perform rating</a> on the shares of Paychex Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) with a price forecast of $148.00.
The company exceeded <a target="_blank" href="https://www.benzinga.com/25/03/44494897/paychex-shares-gain-on-q3-earnings-beat" rel="noreferrer noopener">earnings estimates for the third quarter</a>, reporting revenue of $1.509 billion, a 4.8% year-over-year increase, closely aligning with analyst expectations. Earnings per share came in at $1.49, surpassing estimates.
While Management Solutions and Funds Held for Clients outperformed projections, Professional Employer Organization (PEO) revenue was slightly below forecasts, said the analyst.
The company credited AI investments, digital transformation efforts, and operational efficiencies for driving a 180-basis-point margin expansion. Management also raised full-year operating margin guidance to 43%, the high end of its prior range, citing ongoing cost optimizations and global efficiency improvements.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/03/44491397/dollar-tree-q4-earnings-surpass-estimates-unloads-family-dollar-for-1b" rel="noreferrer noopener">Dollar Tree To Offload Family Dollar Business For $1 Billion</a>
While Paychex observed slight softness in proposal activity early in the quarter, overall demand remained steady, noted the analyst.
Retention rates improved year-over-year and exceeded pre-pandemic levels, driven by strong customer satisfaction. Client losses declined across all employee size segments, reinforcing business stability.
Paychex now expects over $80 million in cost synergies from its acquisition of PYCR, with the deal anticipated to be accretive to EPS in fiscal 2026.
The company maintained its guidance for interest on Funds Held for Clients, projecting $145 million &#8211; $155 million in revenue for fiscal 2025.
PAYX reaffirmed its FY25 revenue growth outlook of 4-5.5% but expects results to land at the lower end due to ongoing challenges in pass-through insurance revenues.
With a ~$150 billion market opportunity, Paychex is well-positioned to expand its footprint in management solutions and PEO services, leveraging strong client retention to maintain or grow its market share.
The company sees potential to increase revenue per client through cross-selling, particularly by offering healthcare solutions to existing ASO clients. With 740,000 payroll and PEO clients, Paychex aims to deepen penetration in HR ancillary services.
Client retention remains near record levels, providing stability in revenue streams. Paychex expects this trend to continue into FY25.
Price Action: PAYX shares traded higher by 0.46% at $150.88 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44497833/exxon-mobil-eyes-semiconductor-boom-with-99-999-pure-isopropyl-alcohol-production-expansion-details" target="_blank" rel="noreferrer noopener">Exxon Mobil Eyes Semiconductor Boom With 99.999% Pure Isopropyl Alcohol Production Expansion: Details</a></li>
</ul>
Image via Shutterstock.

Analyst Color

Equities

Reiteration

General

Paychex Analyst Sees Limited Upside Despite Q3 Profitability Surge

Citigroup analyst Peter Christiansen maintains Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) with a Neutral and raises the price target from $145 to $158.

Citigroup Maintains Neutral on Paychex, Raises Price Target to $158

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Wells Fargo raised Cintas Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) price target from $184 to $186. Wells Fargo analyst Jason Haas maintained an Underweight rating. Cintas shares closed at $204.71 on Wednesday. See how other <a href="https://www.benzinga.com/quote/CTAS/analyst-ratings">analysts view this stock</a>.</li>
<li>Mizuho raised the price target for Axsome Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>) from $212 to $216. Mizuho analyst Graig Suvannavejh maintained an Outperform rating. Axsome Therapeutics shares closed at $119.16 on Wednesday. <a href="https://www.benzinga.com/quote/AXSM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel boosted Paychex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) price target from $141 to $156. Stifel analyst Bryan Bergin maintained a Hold rating. Paychex shares closed at $150.19 on Wednesday. See how other analysts <a href="https://www.benzinga.com/quote/PAYX/analyst-ratings">view this stock</a>.</li>
<li>Piper Sandler raised the price target for Mondelez International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDLZ#NASDAQ">MDLZ</a>) from $56 to $59. Piper Sandler analyst Michael Lavery maintained a Neutral rating. Mondelez shares closed at $66.33 on Wednesday. <a href="https://www.benzinga.com/quote/MDLZ/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank increased the price target for Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from $70 to $75. Deutsche Bank analyst David Begleiter maintained a Buy rating. Celanese shares closed at $59.16 on Wednesday. <a href="https://www.benzinga.com/quote/CE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham cut Constellation Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) price target from $240 to $215. Needham analyst Gerald Pascarelli maintained a Buy rating. Constellation shares settled at $184.11 on Wednesday. <a href="https://www.benzinga.com/quote/STZ/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities raised Check Point Software Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) price target from $230 to $260. B of A Securities analyst Tal Liani upgraded the stock from Neutral to Buy. Check Point Software shares closed at $227.87 on Wednesday. <a href="https://www.benzinga.com/quote/CHKP/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Telsey Advisory Group increased Dollar Tree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) price target from $75 to $82. Telsey Advisory Group analyst Joseph Feldman maintained a Market Perform rating. Dollar Tree shares closed at $69.21 on Wednesday.  <a href="https://www.benzinga.com/quote/DLTR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies cut the price target for Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) from $135 to $120. Jefferies analyst Blayne Curtis downgraded the stock from Buy to Hold. AMD shares settled at $110.19 on Wednesday. <a href="https://www.benzinga.com/quote/AMD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo cut Union Pacific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) price target from $265 to $260. Wells Fargo analyst Christian Wetherbee maintained an Overweight rating. Union Pacific shares closed at $238.03 on Wednesday. <a href="https://www.benzinga.com/quote/UNP/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44496478/top-2-industrials-stocks-that-may-crash-in-q1">Top 2 Industrials Stocks That May Crash In Q1</a></li>
</ul>

AXSM

CHKP

MDLZ

Celanese To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday

Stifel analyst Bryan Bergin maintains Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) with a Hold and raises the price target from $141 to $156.

Stifel Maintains Hold on Paychex, Raises Price Target to $156

U.S. stocks declined on Wednesday, with all major indices in the red by midday in New York, as renewed concerns <a href="https://www.benzinga.com/topic/tariffs">over tariffs rattled investors.</a>
President Donald Trump signaled that new trade duties on automobiles could be announced as early as today, while market participants are also bracing for April 2, which marks the start of reciprocal tariffs.
Technology shares, particularly semiconductor stocks, led the selloff, dragging the Nasdaq 100 sharply lower and trimming much of its weekly gains. Shares of Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) tumbled 5.9%, on track for the worst daily loss since early March, as investors fear further restrictions on chip exports to China. The iShares Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NYSE">SOXX</a>) fell 3.4%. 
Meanwhile, blue-chip stocks in the Dow Jones Industrial Average were more resilient, supported by strength in the energy and consumer staples sectors. The CBOE Volatility Index (VIX), Wall Street's so-called "fear gauge," jumped 8% to 18.9.
The dollar and Treasury yields remained flat, reflecting a wait-and-see stance in the bond market amid uncertainty over the broader economic impact of potential tariffs.
In commodities, crude oil rose 1.4%, extending weekly gains to 2.5%—on track for its best week since early January—after a surprise drop in commercial inventories. Metals held steady, with copper holding record highs.
Bitcoin slipped 1% to $86,500 following a flat close the previous day.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg %</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,552.19</td>
<td>-0.1%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,078.48</td>
<td>-0.9%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,720.71</td>
<td>-1.0%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,980.84</td>
<td>-1.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 1% to $569.92.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) inched 0.2% lower to $424.78.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;dropped 1.7% to $485.01.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) also fell 1% to $205.59</li>
<li>The&nbsp;Consumer Staples&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>) outperformed, up 1.3%; the&nbsp;Technology&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) was the worst sector performer, down 2.1%.</li>
</ul>
<h3 class="wp-block-heading">Wednesday&#8217;s Stock Movers</h3>
<ul>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) skyrocketed 15% in reaction to stronger-than-expected quarterly earnings. The retailer eyes its strongest one-day gain since June 2024. </li>
<li>Other stocks reacting to earnings reports were Cintas Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NYSE">CTAS</a>), up 6.5%, Paychex Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>), up 4.8%, Dollar Tree Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>), up 4.9%, and Chewy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>), up 1.5%. </li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/federal-reserve/25/03/44493432/elevated-consumer-inflation-expectations-raise-the-bar-for-possible-rate-cuts-this-year-goldman-sachs">Elevated Consumer Inflation Expectations &#8216;Raise The Bar For Possible Rate Cuts This Year&#8217;: Goldman Sachs</a></li>
</ul>
Photo: Shutterstock

Government

Large Cap

Macro Economic Events

Regulations

Broad U.S. Equity ETFs

Econ #s

Economics

ETFs

CHWY

SPDR Dow Jones Industrial Average ETF Trust

NVDA

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

Stocks Slip As Tariff Fears Resurface: What's Driving Markets Wednesday?

U.S. stocks were mixed, with the Dow Jones index gaining around 100 points on Wednesday.
Shares of Paychex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) rose sharply during Wednesday's session after the company reported <a href="https://in.benzinga.com/25/03/44494897/paychex-shares-gain-on-q3-earnings-beat">better-than-expected quarterly adjusted EPS.</a>
The company reported third-quarter revenue growth of 5% year-on-year to $1.509 billion, marginally missing the analyst consensus estimate of $1.516 billion. Adjusted EPS of $1.49 beat the consensus estimate of $1.48.
Paychex shares jumped 5.5% to $152.02 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Playtika Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTK#NASDAQ">PLTK</a>) shares jumped 23.2% to $5.42.</li>
<li>Worthington Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>) gained 18.4% to $49.31 as the company posted better-than-expected earnings for the third quarter.</li>
<li>Perimeter Solutions, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRM#NYSE">PRM</a>) rose 15% to $10.48 after UBS upgraded the stock from Neutral to Buy and announced a price target of $14.</li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) gained 14.3% to $29.05 after the company reported better-than-expected quarterly adjusted EPS and announced its board approved an update to its investment policy to add Bitcoin as a treasury reserve asset.</li>
<li>Super Hi International Holding Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HDL#NASDAQ">HDL</a>) gained 10.6% to $24.47 following fourth-quarter results.</li>
<li>BRP Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOOO#NASDAQ">DOOO</a>) gained 9.9% to $39.06 following better-than-expected quarterly earnings.</li>
<li>Cintas Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) surged 9.6% to $212.18 following better-than-expected quarterly earnings.</li>
<li>JinkoSolar Holding Co., Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JKS#NYSE">JKS</a>) gained 7.8% to $22.33 following fourth-quarter results.</li>
<li>Ashland Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) rose 5.7% to $60.16. JP Morgan analyst Jeffrey Zekauskas upgraded Ashland from Neutral to Overweight and raised the price target from $68 to $71.</li>
<li>Weatherford International plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFRD#NASDAQ">WFRD</a>) rose 4.7% to $57.41.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44492633/jim-cramer-palantir-is-a-winner-recommends-selling-this-tech-stock">Jim Cramer: Palantir Is A &#8216;Winner,&#8217; Recommends Selling This Tech Stock</a></li>
</ul>
Image: Shutterstock

Intraday Update

Movers

DOOO

PLTK

WFRD

Paychex Posts Better-Than-Expected Earnings, Joins Worthington Enterprises, GameStop, Cintas And Other Big Stocks Moving Higher On Wednesday

WIIM

Paychex shares are trading higher after the company reported better-than-expected Q3 adjusted EPS.

Shares of Paychex Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading higher on Wednesday</a> after the third-quarter earnings.
The company reported third-quarter revenue growth of 5% year-on-year to $1.509 billion, marginally missing the <a href="https://www.benzinga.com/pressreleases/25/03/b44492466/paychex-inc-reports-third-quarter-results">analyst consensus estimate of $1.516 billion.</a>
Adjusted EPS of $1.49 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the consensus estimate of $1.48.</a>
Management Solutions revenue increased 5% to $1.1 billion and Professional Employer Organization (PEO) and Insurance Solutions revenue gained 6% to $365.4 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44457612/tilrays-hiball-energy-returns-to-whole-foods-market-details" rel="noreferrer noopener">Tilray&#8217;s Hi&#x2A;Ball Energy Returns To Whole Foods Market</a>
Total expenses increased 4% to $817.2 million due to acquisition-related costs associated with the pending Paycor acquisition, increase in PEO direct insurance costs and investment in product, technology, data, and AI.
Operating income for the quarter increased 6% to $691.8 million and the operating margin expanded 70 basis points to 45.8%.
Adjusted EBITDA climbed 8% to $751.6 million. Paychex held $2.39 billion in total cash and equivalents as of February 28, 2025.
The operating cash flow for nine months totaled $1.6 billion. Repurchased 828,855 shares for $104.0 million and paid cumulative dividends of $2.94 per share totaling $1.1 billion for the nine months.
The Paycor acquisition is expected to close in April 2025, subject to other customary closing conditions.
&#8220;The third quarter of this fiscal year has been a transformational time at Paychex. As we position ourselves for the digitally and AI driven future of human capital management (&#8220;HCM&#8221;), we believe the combination of our continued positive momentum and the pending acquisition of Paycor positions Paychex for continued growth,&#8221; said President and CEO John Gibson.
Outlook: PEO and Insurance Solutions revenue is now anticipated to grow in the range of 6.0% to 6.5%. Adjusted operating margin is anticipated to be approximately 43%.
Price Action: PAYX shares traded higher by 6.06% at $152.87 at last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44475168/cognizant-partners-with-nvidia-to-enhance-enterprise-operations-with-neuro-ai-platform" target="_blank" rel="noreferrer noopener">Cognizant Boosts Stock Buyback, Partners With NVIDIA To Enhance Enterprise Operations With Neuro AI Platform</a></li>
</ul>
Image via Shutterstock.

Guidance

Paychex Q3 Earnings: EPS Beat, Strong Margins, Paycor Deal Nears Completion And More

Paychex Sees PEO And Insurance Solutions Revenue Growth of 6% - 6.5%

Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) reported quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.48 by 0.68 percent. This is a 7.97 percent increase over earnings of $1.38 per share from the same period last year. The company reported quarterly sales of $1.51 billion which met the analyst consensus estimate. This is a 4.86 percent increase over sales of $1.44 billion the same period last year.

Earnings Beats

Paychex Q3 Adj $1.49 Beats $1.48 Estimate, Sales $1.51B Inline

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the &#8220;Fear&#8221; zone on Tuesday.
U.S. stocks settled slightly higher on Tuesday, extending gains from the previous session with investors awaiting more clarity on tariff developments and digested a downbeat consumer confidence report.
On the economic data front, the Conference Board's monthly confidence index declined to a reading of 92.9, compared to market estimates of 93.5. The S&amp;P CoreLogic Case-Shiller home price index increased 4.7% year-over-year in January, versus a 4.5% increase in December, but down from market estimates of a 4.8% increase. Sales of new single-family homes increased 1.8% to an annual rate of 676,000 in February, following a revised 6.9% decline in the previous month, and down from market estimates of 680,000.
CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) shares gained over 3% on Tuesday after BTIG analyst Gray Powell upgraded the stock to Buy, setting a price target of $431.
Most sectors on the S&amp;P 500 closed on a positive note, with consumer discretionary, communication services and financial stocks recording gains on Tuesday. However, utilities and health care stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 4 points to 42,587.50 on Tuesday. The S&amp;P 500 rose 0.16% to 5,776.65, while the Nasdaq Composite climbed 0.46% at 18,271.86 during Tuesday's session.
Investors are awaiting earnings results from Dollar Tree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>), Paychex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) and Cintas Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) today.
At a current reading of 28.8, the index remained in the &#8220;Fear&#8221; zone on Tuesday, versus a prior reading of 29.8.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next:
<ul>
<li> <a href="https://www.benzinga.com/25/03/44471817/top-2-health-care-stocks-that-are-ticking-portfolio-bombs-3">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

CRWD

S&P Settles Slightly Higher As Investors Assess Economic Data; Investor Fear Increases, Fear & Greed Index Remains In 'Fear' Zone

With U.S. stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Dollar Tree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) to report quarterly earnings at $2.19 per share on revenue of $8.24 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Dollar Tree shares gained 0.3% to $67.32 in after-hours trading.</li>
<li>GameStop Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) reported fourth-quarter financial results after the market close on Tuesday. The company reported fourth-quarter revenue of $1.283 billion, missing the consensus estimate of $1.48 billion. The video game retailer reported fourth-quarter adjusted earnings of 30 cents per share, beating analyst estimates of eight cents per share. In a separate press release, GameStop announced its board unanimously approved an update to investment policies to add Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) as a treasury reserve asset. GameStop shares climbed 8.3% to $27.50 in the after-hours trading session.</li>
<li>Analysts are expecting Paychex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) to post quarterly earnings at $1.48 per share on revenue of $1.52 billion. The company will release earnings before the markets open. Paychex shares rose 2.3% to $147.38 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Worthington Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>) posted better-than-expected earnings for the third quarter on Tuesday. Worthington shares gained 3.2% to $42.95 in the after-hours trading session.</li>
<li>Analysts expect Cintas Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) to post quarterly earnings at $1.06 per share on revenue of $2.60 billion before the opening bell. Cintas shares rose 0.8% to $195.00 in after-hours trading.</li>
</ul>
Check This Out:<a href="https://www.benzinga.com/25/03/44471817/top-2-health-care-stocks-that-are-ticking-portfolio-bombs-3"> </a>
<ul>
<li><a href="https://www.benzinga.com/25/03/44471817/top-2-health-care-stocks-that-are-ticking-portfolio-bombs-3">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

Dollar Tree, GameStop And 3 Stocks To Watch Heading Into Wednesday

<h3>Companies Reporting Before The Bell</h3>
• Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) is estimated to report quarterly loss at $5.00 per share on revenue of $5.60 million. 
• Dollar Tree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) is projected to report quarterly earnings at $2.18 per share on revenue of $8.23 billion. 
• Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $3.20 billion. 
• Titan America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTAM#NYSE">TTAM</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $384.72 million. 
• Cintas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) is likely to report quarterly earnings at $1.06 per share on revenue of $2.60 billion. 
• SailPoint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIL#NASDAQ">SAIL</a>) is expected to report quarterly loss at $0.03 per share on revenue of $202.71 million. 
• REX American Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REX#NYSE">REX</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $152.00 million. 
• CollPlant Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLGN#NASDAQ">CLGN</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $358 thousand. 
• Target Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TH#NASDAQ">TH</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $80.10 million. 
• JinkoSolar Holding Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JKS#NYSE">JKS</a>) is estimated to report quarterly loss at $0.46 per share on revenue of $3.59 billion. 
• BRP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOOO#NASDAQ">DOOO</a>) is expected to report quarterly earnings at $0.62 per share on revenue of $1.35 billion. 
• Canaan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) is expected to report quarterly loss at $0.14 per share on revenue of $88.50 million. 
• Precision BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) is expected to report quarterly loss at $2.94 per share on revenue of $4.28 million. 
• Cheetah Mobile (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMCM#NYSE">CMCM</a>) is expected to report earnings for its fourth quarter. 
• Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) is projected to report quarterly earnings at $1.48 per share on revenue of $1.51 billion. 
• Zhihu (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZH#NYSE">ZH</a>) is projected to report earnings for its fourth quarter. 
<h3>Companies Reporting After The Bell</h3>
• Snail (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNAL#NASDAQ">SNAL</a>) is estimated to report earnings for its fourth quarter. 
• Integra Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ITRG#AMEX">ITRG</a>) is likely to report earnings for its fourth quarter. 
• TAT Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TATT#NASDAQ">TATT</a>) is likely to report earnings for its fourth quarter. 
• Envela (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELA#AMEX">ELA</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $40.63 million. 
• 3D Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) is projected to report quarterly loss at $0.11 per share on revenue of $114.96 million. 
• BioCardia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) is projected to report quarterly loss at $0.87 per share on revenue of $20 thousand. 
• Oxbridge Re Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXBR#NASDAQ">OXBR</a>) is projected to report earnings for its fourth quarter. 
• Durect (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRRX#NASDAQ">DRRX</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $6.91 million. 
• Journey Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DERM#NASDAQ">DERM</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $14.21 million. 
• Zepp Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZEPP#NYSE">ZEPP</a>) is expected to report earnings for its fourth quarter. 
• FGI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGI#NASDAQ">FGI</a>) is projected to report quarterly loss at $0.03 per share on revenue of $33.09 million. 
• Jefferies Financial Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>) is projected to report quarterly earnings at $1.13 per share on revenue of $1.97 billion. 
• Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) is estimated to report quarterly loss at $0.08 per share on revenue of $2.10 million. 
• H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) is projected to report quarterly earnings at $0.63 per share on revenue of $797.68 million. 
• Dyadic International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYAI#NASDAQ">DYAI</a>) is expected to report quarterly loss at $0.06 per share on revenue of $1.35 million. 
• Usio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USIO#NASDAQ">USIO</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $21.40 million. 
• Verint Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNT#NASDAQ">VRNT</a>) is estimated to report quarterly earnings at $1.27 per share on revenue of $276.82 million. 
• Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) is estimated to report quarterly earnings at $3.01 per share on revenue of $2.47 billion. 
• Spruce Power Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPRU#NYSE">SPRU</a>) is projected to report earnings for its fourth quarter. 
• Steelcase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCS#NYSE">SCS</a>) is likely to report quarterly earnings at $0.21 per share on revenue of $790.90 million. 
• Guardian Pharmacy Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRDN#NYSE">GRDN</a>) is projected to report quarterly earnings at $0.20 per share on revenue of $320.52 million. 
• Perspective Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CATX#AMEX">CATX</a>) is expected to report quarterly loss at $0.26 per share on revenue of $232 thousand. 
• MillerKnoll (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) is projected to report quarterly earnings at $0.44 per share on revenue of $918.88 million. 
• Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $87.50 million. 
• Inventiva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVA#NASDAQ">IVA</a>) is estimated to report earnings for its Fiscal Year 2024. 
• Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) is projected to report quarterly earnings at $0.01 per share on revenue of $1.56 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALUR

ALVO

BCDA

CATX

CLGN

CMCM

CNXC

DERM

DRRX

DTIL

DYAI

GRDN

ITRG

MLKN

MVIS

OXBR

SAIL

SNAL

Spruce Power Holding Corporation Class A Common Stock

SPRU

TATT

TTAM

USIO

VRNT

WOOF

ZEPP

Earnings Scheduled For March 26, 2025

Paychex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) will release its third-quarter financial results before the <a href="https://www.benzinga.com/quote/payx/earnings">opening bell on Wednesday, March 26.</a>
Analysts expect the Rochester, New York-based company to report quarterly earnings at $1.48 per share, up from $1.38 per share in the year-ago period. Paychex projects quarterly revenue of $1.51 billion, compared to $1.44 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On March 4, UBS analyst Kevin Mcveigh maintained Paychex with a Neutral rating and raised the price target from $152 to $155.
Paychex shares fell 0.5% to close at $144.13 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/PAYX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Barclays analyst Ramsey El-Assal maintained an Equal-Weight rating and raised the price target from $135 to $140 on Dec. 23, 2024. This analyst has an accuracy rate of 65%.</li>
<li>RBC Capital analyst Ashish Sabadra reiterated a Sector Perform rating with a price target of $148 on Dec. 20, 2024. This analyst has an accuracy rate of 72%.</li>
<li>TD Cowen analyst Bryan Bergin maintained a Hold rating and increased the price target from $131 to $146 on Dec. 3, 2024. This analyst has an accuracy rate of 66%.</li>
<li>JP Morgan analyst Tien-Tsin Huang maintained an Underweight rating and increased the price target from $133 to $139 on Nov. 19, 2024. This analyst has an accuracy rate of 65%.</li>
<li>Citigroup analyst Peter Christiansen reiterated a Neutral rating with a price target of $145 on Oct. 2, 2024. This analyst has an accuracy rate of 65%.</li>
</ul>
Considering buying PAYX stock? Here&#8217;s what analysts think: 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44471817/top-2-health-care-stocks-that-are-ticking-portfolio-bombs-3">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

Paychex Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

JEPI

CNBC Halftime Report Final Trades: Paychex, Pfizer, JPMorgan Equity Premium Income ETF

UBS analyst Kevin Mcveigh maintains Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) with a Neutral and raises the price target from $152 to $155.

UBS Maintains Neutral on Paychex, Raises Price Target to $155

Press Releases

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: H&E Equipment Services, Inc. (Nasdaq - HEES), Inari Medical, Inc. (Nasdaq - NARI), Paycor HCM, Inc. (Nasdaq - PYCR), Shutterstock, Inc. (NYSE - SSTK)

Job Growth in U.S. Small Businesses Continues the Pace Seen in the Back Half of 2024

Paychex Announces Expiration of HSR Waiting Period for Paychex's Acquisition of Paycor

U.S. Small Business Employment Remains Stable in February

Ethisphere Names Paychex Among World's Most Ethical Companies® for 17th Time

Paychex, Inc. Schedules Third Quarter Fiscal 2025 Earnings Conference Call for March 26, 2025

Paychex Survey Finds AI is Empowering Small Businesses, with 72% Feeling Positive

Paychex, Inc. Reports Third Quarter Results

Paychex Named Among Fortune's Most Innovative Companies

Paychex Small Business Jobs Index Shows Little Change in March and Levels Consistent with Last Several Quarters

Comments

Paychex

Notizie

Ultime notizie per Paychex (NASDAQ:PAYX) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO